Analysis of domestic veterinary drug raw materials market in the 42nd week of 2021
Special Note
1. After the API China meeting, the explosive full jump mode was launched. Amoxicillin, Ampicillin, and penicillin potassium industrial salt are still on the sidelines, and there are no quotations on the market.
2. Hot products this week: Analgin, Enrofloxacin
3. Products with large price increases include florfenicol, sulfa products, quinolone products, Paracetamol, acemetaquine, spectinomycin hydrochloride, and taurine.
Cephalosporins and Penicillins
Ceftiofur Sodium, ceftiofur hydrochloride, prices rise, ceftiofur hydrochloride 1860, ceftiofur sodium 2380
Cefquinome Sulfate, the price goes up, the supply is small, the market demand is stable, the price is 8,200
Amoxicillin, the price has risen sharply recently, the market is in a state of suspension
Amoxicillin sodium, market price 465
Potassium amoxicillin and clavulanate, strong momentum, stable trading volume
Ampicillin and ampicillin sodium are strong, the market price of ampicillin is 220, and ampicillin sodium is 280
Penicillin sodium (potassium), the price goes up, the market price of penicillin sodium is 320, the price of penicillin potassium industrial salt is more than 100, the price of the same period last year is 80, a sharp increase, the price of the same period in 2019 is 61, the overall trend is rising year by year
Aminoglycosides
The price of kanamycin monosulfate rose sharply this week. The market responded quickly. The market price was 305. The price in January of this year was 270. The price started to rise in February. The price reached 300 at the end of July. After a slight correction in August, the price continued to be high. Under the policy of stability and dual control of energy consumption, prices have repeatedly broken through. The price in the same period of 2020 is 272, and the price in the same period of 2019 is 271. As a stable product throughout the year, kanamycin monosulfate has a strong position this year.
The price of neomycin sulfate increased by 152-157 due to the market influence. The market is still showing an upward trend. The price in the third quarter remained in the range of 137-145. In recent years, market competition has been fierce. The overall operation of neomycin sulfate this year is relatively low-key. , The price trend is cautious. Under the policy of "dual energy consumption control", the price increase is relatively large, and the Asia-Pacific e-he data analysis center focuses on
Spectinomycin hydrochloride, the price rises, the market price is above 565
Gentamicin sulfate, low price
Streptomycin sulfate, the market quotation increased, and the transaction price strengthened 248-278
Apramycin sulfate, driven by various factors, increased market attention, and price continued to be concerned
Tetracycline and Chloramphenicol
Doxycycline hydrochloride continues to rise, the price is like a broken bamboo, the supply of goods is relatively balanced, the rhythm of shipments is stable, and the market price is above 700
Oxytetracycline and oxytetracycline hydrochloride are on the strong side, and market inquiries and concerns have increased. The transaction price of oxytetracycline is 82-86. Oxytetracycline hydrochloride market price 101-108
Chlortetracycline hydrochloride, up slightly, the market price is 218
Florfenicol, a hot product recently, has been low-key for a summer. Affected by intermediates and dual-control policies, manufacturers are in short supply and stopped taking orders. The trading market is reluctant to sell. The price continues to rise by leaps, and there are no goods available, which is beyond the scope of rational acceptance. , There is a phenomenon of rush for goods, the market price is more than 700, the Asia-Pacific data analysis center focuses on products
Macrolides
The price of erythromycin thiocyanate rose, and the transaction price was stable at 357-373. The price of the same period in 2020 was 340, an increase of 5.9%, the price of the same period in 2019 was 330, and the price of the same period in 2018 was 465, the peak moment.
Tylosin tartrate began to open an upward channel in the third quarter, the price was firm, rose slightly, and the market quotation exceeded 300. Tylosin is an intermediate of many products, and its price changes have caused a chain reaction. The price in the same period in 2020 is 235, the price in the same period in 2019 is 240, and the price in the same period in 2018 is 415.
Lincomycin hydrochloride was stable and weak, and the transaction price ranged from 332 to 345. The price was strong in the first half of the year. In the second half of the year, affected by the market, the price was slightly weak, and the price continued to fall after August.
The price of colistin sulfate continues to rise at a high level. The market price is around 115. It is a bulk product with a large terminal consumption and active market transactions. The current price is stable at a high level. The price of the same period in 2020 is 104, the price of the same period in 2019 is 95.
Tiamulin fumarate is operating on a strong side, and the rising range has narrowed. The market reaction is dull and rational, and the transaction volume has not risen significantly. The current price is 295-315. The average price in January was 262, rose to 320 in February, 346 in March, 325 in April, and 308 in May. The price continued to fall in June, reaching a low of 260. In July, it began to strengthen at 275. In August, the price rose to 298. In September The price is around 300, under the dual control policy, singing all the way.
Tyvanin tartrate, high volatility, sufficient upstream supply, weak terminal market demand, wide market quotation range, transaction price 750-790, the market transaction price in mid-December last year was 625, the supply began to be tight in the second half of the year, and the price rose straightly and continued. By the end of March this year, the supply of goods has been eased. After April, the supply of goods has increased. The transaction price in May was 800-826. In June, the price fluctuated at a high level. The price declined in July. The price has remained stable since August.
Tilmicosin, Tilmicosin Phosphate, the prices have been raised, and market transactions are active. Tilmicosin quotations are above 460, the price of 345 in the same period in 2020, and the price in 2019 is 341; the market quotation of Tilmicosin phosphate is above 410, an increase from the previous month 8.1%, the price of the same period in 2020 is 325, a year-on-year increase of 28.2%
Sulfonamides and Quinolones
Sulfonamide products rose collectively, and sulfamonomethoxine sodium rose sharply. Under the tight raw materials and the dual control policy, the continuous jump has become unstoppable, and the supply of goods is tight, and the spot must be king. Asia-Pacific Yihe Data Analysis Center focuses on products
Sulfadiazine (sodium), the price rises, affected by the production capacity, the quotation increased by 265, the price of the same period last year was 245
Sulfamethazine (sodium), the transaction price goes up, the market price is 115
Sulfamethoxazole (sodium), the price has increased greatly
Sulfonamide versus methoxypyrimidine (sodium), strong operation and active trading
Sulfamonomethoxine (sodium), affected by various factors such as raw material intermediates, has a large price increase, and market transactions are active. The quoted price is 360-385. The overall performance this year is strong. Affected by intermediates, upstream manufacturers maintain low inventories, the overall market supply is tight, and prices continue to run at a high level. Recently, affected by the market and policies, prices have strengthened again and supply has become more tight.
Sulfachloropyrazine sodium, the price went up, the transaction price was 372, the price of the same period last year was basically the same in the range of 365-370, and the price of the same period in 2019 was 385
Sulfachlordazine Sodium, the market is stable and the price is high, the market price is 342, an increase of 11.9% year-on-year
Sulfaquinoxaline Sodium, the price is rising, the market price is above 370
The prices of trimethoprim and trimethoprim lactate have increased significantly. The transaction price of trimethoprim lactate is a mystery, with a price of 179 in the same period last year; the market quotation of trimethoprim has exceeded 250, 235 in the same period last year, an increase of 6.9%
Ditrimethoprim (DVD), the price is too strong to run 385
Prices of quinolone products remained high, manufacturers stopped reporting, and the trading market responded quickly. Affected by the "dual control of energy consumption" and limited production, manufacturers have increased their ex-factory prices twice in September.
Enrofloxacin and enrofloxacin hydrochloride prices are firm, enrofloxacin quotations have increased, and low-priced inventories have decreased. The market quotation is above 245, and the price of enrofloxacin in the same period last year was 205, an increase of 19.5%.
The prices of ciprofloxacin lactate and ciprofloxacin hydrochloride went up, the market price was 240, a year-on-year increase of 17.2%, and the price in the same period of 2019 was 195
Sarafloxacin hydrochloride, the price goes up
Marbofloxacin, price strength
Looking for chemical products? Let suppliers reach out to you!
2026-06-19
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Market Analysis of Domestic Veterinary Drug Raw Materials in the 34th Week of 2022
-
The Veterinary Drug Industry is Facing a Period of Opportunity for Change, and Leading Animal Health Companies are Expected to Grow Rapidly
-
Analysis of China's Veterinary Drug Raw Material Market in the 32nd Week of 2022(1)
-
Analysis of the Domestic Veterinary Drug Raw Material Market in the 28th Week of 2022
-
Week 21 Partial Veterinary Drug Quotes 2
-
Analysis of The Veterinary Drug Raw Material Market in the 21st Week
-
Market Analysis of Veterinary Drug Raw Materials
-
Continue to Crack Down On The Illegal Use of Veterinary Drugs And Additives in 2022
-
Many Factors Affecting The Price Trend of Veterinary Drug Raw Materials
-
Market Analysis of Veterinary Drug Feed Ingredients - VPi Down
Recommend Reading
-
Zydus Brings the First Keytruda Biosimilar Showdown to North America
-
U.S. FDA Opens New Safety Review of RSV Treatments for Infants
-
Smog Becomes a Sales Catalyst as Respiratory Drugs Surge in November
-
The FDA Officially Blesses AI for Liver Drug Development
-
Wegovy Slips on Price While Mounjaro Defends Its Weight-Loss Crown
-
This Week's PVC Market Rebounds (12.22-26)
-
Focusing on the Risks of the Strait of Hormuz: Safety of Ethylene Glycol Imports to China and Price Trend Predictions
-
11 Billion Euro Cut BASF Slashes 2025 Outlook as Q2 Earnings Plunge and Strategic Moves Accelerate
-
Euro Surges 12 Percent Against Yuan Reaching 11-Year High
-
Negative Factors Pressuring, October Sees Falling Trends in Shandong Cyclohexanone Market